Skip to main content

Table 1 Baseline characteristics of included patients

From: Association between red cell distribution width-to-platelet ratio and short-term and long-term mortality risk in patients with acute ischemic stroke

Variables

Total (n = 1358)

RPR ≤ 0.11 (n = 1176)

RPR > 0.11 (n = 182)

Statistics

P

Age, years, Mean ± SD

68.76 ± 15.60

68.56 ± 15.86

70.08 ± 13.77

t = -1.36

0.175

Gender, n (%)

   

χ2 = 0.122

0.726

 Female

685 (50.44)

591 (50.26)

94 (51.65)

  

 Male

673 (49.56)

585 (49.74)

88 (48.35)

  

Ethnicity, n (%)

   

χ2 = 2.020

0.568

 Black

121 (8.91)

104 (8.84)

17 (9.34)

  

 Others

164 (12.08)

138 (11.73)

26 (14.29)

  

 Unknown

93 (6.85)

84 (7.14)

9 (4.95)

  

 White

980 (72.16)

850 (72.28)

130 (71.43)

  

Insurance, n (%)

   

χ2 = 0.759

0.684

 Medicare

848 (62.44)

733 (62.33)

115 (63.19)

  

 Others

136 (10.01)

121 (10.29)

15 (8.24)

  

 Private

374 (27.54)

322 (27.38)

52 (28.57)

  

Ventilation, n (%)

   

χ2 = 23.297

 < 0.001

 No

636 (46.83)

581 (49.40)

55 (30.22)

  

 Yes

722 (53.17)

595 (50.60)

127 (69.78)

  

Vasopressor, n (%)

   

χ2 = 35.141

 < 0.001

 No

884 (65.10)

801 (68.11)

83 (45.60)

  

 Yes

474 (34.90)

375 (31.89)

99 (54.40)

  

Rrt, n (%)

   

χ2 = 13.020

 < 0.001

 No

1285 (94.62)

1123 (95.49)

162 (89.01)

  

 Yes

73 (5.38)

53 (4.51)

20 (10.99)

  

Iv-tPA, n (%)

   

χ2 = 20.859

 < 0.001

 No

1121 (82.55)

949 (80.70)

172 (94.51)

  

 Yes

237 (17.45)

227 (19.30)

10 (5.49)

  

Beta blockers, n (%)

   

χ2 = 1.275

0.259

 No

1264 (93.08)

1091 (92.77)

173 (95.05)

  

 Yes

94 (6.92)

85 (7.23)

9 (4.95)

  

Endovascular treatment, n (%)

   

χ2 = 2.627

0.105

 No

1268 (93.37)

1093 (92.94)

175 (96.15)

  

 Yes

90 (6.63)

83 (7.06)

7 (3.85)

  

Weight, kg, Mean ± SD

78.17 ± 17.85

78.27 ± 17.70

77.55 ± 18.82

t = 0.50

0.616

SBP, mmHg, Mean ± SD

138.54 ± 28.30

140.81 ± 28.27

123.89 ± 23.80

t = 8.69

 < 0.001

DBP, mmHg, Mean ± SD

69.88 ± 18.32

70.46 ± 18.37

66.17 ± 17.56

t = 2.95

0.003

Respiratory rate, bpm, Mean ± SD

18.26 ± 5.18

18.15 ± 5.08

18.95 ± 5.75

t = -1.76

0.079

Heart rate, bpm, Mean ± SD

83.72 ± 18.97

82.93 ± 18.64

88.82 ± 20.30

t = -3.91

 < 0.001

Temperature, °C, Mean ± SD

36.61 ± 0.95

36.62 ± 0.90

36.55 ± 1.23

t = 0.68

0.494

SpO2, %, Mean ± SD

98.02 ± 2.40

98.01 ± 2.41

98.09 ± 2.32

t = -0.43

0.667

SAPSII, score, M (Q1, Q3)

35.00 (27.00, 45.00)

34.00 (26.00, 43.00)

44.00 (35.00, 54.00)

Z = 8.324

 < 0.001

SOFA, score, M (Q1, Q3)

3.00 (2.00, 6.00)

3.00 (2.00, 5.00)

6.00 (4.00, 9.00)

Z = 12.395

 < 0.001

qSOFA, score, M (Q1, Q3)

2.00 (1.00, 2.00)

2.00 (1.00, 2.00)

2.00 (1.00, 2.00)

Z = 1.969

0.049

GCS, score, Mean ± SD

12.53 ± 3.34

12.54 ± 3.26

12.42 ± 3.80

t = 0.41

0.679

CCI, M (Q1, Q3)

6.00 (5.00, 8.00)

6.00 (5.00, 8.00)

7.00 (5.00, 9.00)

Z = 4.064

 < 0.001

INR, ratio, M (Q1, Q3)

1.22 (1.10, 1.40)

1.20 (1.10, 1.30)

1.40 (1.20, 1.80)

Z = 8.418

 < 0.001

Diabetes, n (%)

   

χ2 = 8.335

0.004

 No

448 (32.99)

405 (34.44)

43 (23.63)

  

 Yes

910 (67.01)

771 (65.56)

139 (76.37)

  

Congestive heart failure, n (%)

   

χ2 = 0.934

0.334

 No

959 (70.62)

836 (71.09)

123 (67.58)

  

 Yes

399 (29.38)

340 (28.91)

59 (32.42)

  

Atrial fibrillation, n (%)

   

χ2 = 6.051

0.014

 No

1004 (73.93)

883 (75.09)

121 (66.48)

  

 Yes

354 (26.07)

293 (24.91)

61 (33.52)

  

Acute myocardial infarction, n (%)

   

χ2 = 0.455

0.500

 No

718 (52.87)

626 (53.23)

92 (50.55)

  

 Yes

640 (47.13)

550 (46.77)

90 (49.45)

  

Hypertension, n (%)

   

χ2 = 0.085

0.770

 No

1200 (88.37)

1038 (88.27)

162 (89.01)

  

 Yes

158 (11.63)

138 (11.73)

20 (10.99)

  

Cardiogenic shock, n (%)

   

χ2 = 0.260

0.610

 No

455 (33.51)

391 (33.25)

64 (35.16)

  

 Yes

903 (66.49)

785 (66.75)

118 (64.84)

  

Acute kidney injury, n (%)

   

-

1.000

 No

1333 (98.16)

1154 (98.13)

179 (98.35)

  

 Yes

25 (1.84)

22 (1.87)

3 (1.65)

  

Myocardial infarct, n (%)

   

χ2 = 0.616

0.432

No

1129 (83.14)

974 (82.82)

155 (85.16)

  

Yes

229 (16.86)

202 (17.18)

27 (14.84)

  

WBC, K/uL, M (Q1, Q3)

11.10 (8.30, 14.20)

11.20 (8.60, 14.10)

9.80 (6.40, 14.70)

Z = -2.871

0.004

Platelet, K/uL, M (Q1, Q3)

215.00 (163.00, 278.00)

232.00 (186.00, 288.00)

101.00 (66.00, 121.00)

Z = -21.420

 < 0.001

Hemoglobin, g/dL, Mean ± SD

11.54 ± 2.12

11.79 ± 2.02

9.92 ± 2.08

t = 11.63

 < 0.001

RDW, %, Mean ± SD

14.53 ± 1.80

14.31 ± 1.58

16.02 ± 2.36

t = -9.45

 < 0.001

Creatinine, mg/dL, M (Q1, Q3)

0.90 (0.70, 1.20)

0.90 (0.70, 1.20)

1.00 (0.70, 1.50)

Z = 3.229

0.001

PT, seconds, M (Q1, Q3)

13.72 (13.10, 15.20)

13.69 (13.00, 14.70)

15.25 (13.70, 17.90)

Z = 8.456

 < 0.001

BUN, mg/dL, M (Q1, Q3)

18.00 (13.00, 26.00)

17.00 (13.00, 25.00)

23.00 (14.00, 35.00)

Z = 5.204

 < 0.001

Glucose, mg/dL, M (Q1, Q3)

131.00 (108.00, 165.00)

131.00 (108.00, 164.00)

139.50 (113.00, 178.00)

Z = 1.947

0.052

Sodium, mEq/L, Mean ± SD

139.14 ± 4.37

139.16 ± 4.31

139.01 ± 4.75

t = 0.45

0.655

Potassium, mEq/L, Mean ± SD

4.04 ± 0.71

4.03 ± 0.71

4.10 ± 0.76

t = -1.09

0.275

Chloride, mEq/L, Mean ± SD

105.64 ± 5.37

105.41 ± 5.13

107.14 ± 6.54

t = -3.43

 < 0.001

LOS, days, M (Q1, Q3)

3.61 (1.96, 7.86)

3.23 (1.90, 7.06)

6.17 (2.99, 11.37)

Z = 6.462

 < 0.001

Outcome, n (%)

   

χ2 = 18.819

 < 0.001

 Death

1038 (76.44)

922 (78.40)

116 (63.74)

  

 Survival

320 (23.56)

254 (21.60)

66 (36.26)

  

30-day stay, days, M (Q1, Q3)

30.00 (22.05, 30.00)

30.00 (24.62, 30.00)

30.00 (10.14, 30.00)

Z = -3.237

0.001

30-day outcome, n (%)

   

χ2 = 12.372

 < 0.001

 Death

983 (72.39)

871 (74.06)

112 (61.54)

  

 Survival

375 (27.61)

305 (25.94)

70 (38.46)

  

1-year stay, days, M (Q1, Q3)

365.00 (22.05, 365.00)

365.00 (24.62, 365.00)

116.08 (10.14, 365.00)

Z = -5.158

 < 0.001

1-year outcome, n (%)

   

χ2 = 35.746

 < 0.001

 Death

798 (58.76)

728 (61.90)

70 (38.46)

  

 Survival

560 (41.24)

448 (38.10)

112 (61.54)

  
  1. t t-test, Z wilcoxon rank sum test, χ2 chi-square test, SD standard deviation, M Median, Q1 1st Quartile, Q3 3st Quartile, RPR red cell distribution width (RDW) to platelet ratio, Rrt renal replacement therapy, Iv-tPA tissue-type plasminogen activator, SBP systolic blood pressure, DBP diastolic blood pressure, SAPSII simplified acute physiology score II, SOFA sequential organ failure assessment, qSOFA quick sepsis-related organ failure assessment, GCS Glasgow Coma Scale, CCI charlson’s comorbidity index, INR international normalized ratio, WBC white blood cell, PT prothrombin time, BUN blood urea nitrogen, LOS length of stay